WuXi Biologics is a leading global Contract Research, Development, and Manufacturing Organization (CRDMO) for biologics, with over 12,000 employees across the US, Ireland, Germany, China, and Singapore. The company provides end-to-end solutions from discovery through commercial manufacturing for biologics including monoclonal antibodies, bispecifics, ADCs, vaccines, and mRNA products using both mammalian and microbial expression systems.
End-to-end biologics CRDMO with mammalian and microbial expression platforms, proprietary discovery technologies, 120,000L+ manufacturing capacity, and global cGMP facilities across multiple continents.
5 sites worldwide
No reviews available yet.
No documents available.